Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Pasithea Therapeutics Corp. (KTTA)
USD0.48
0.00 (-0.81%)
US NASDAQ Healthcare Biotechnology
Address
1111 Lincoln Road 33139
Miami Beach, FL, US
Miami Beach, FL, US
CEO
Tiago Reis Marques
Website
pasithea.com
IPO
2021-09-15
CIK 1841330 ISIN US70261F2020
Also trades on
NASDAQ Capital Market · KTTA (USD)
NASDAQ Capital Market · KTTAW (USD)
Description
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.48
0.00 (-0.81%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
862.6K
Beta
0.25
Float Shares
7.32M
Free Float %
98.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.78% | +2.64% | +5.08% | +12.62% | +6.85% | -39.53% | -17.18% | -88.53% | -98.90% | -98.90% | -98.90% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
0.48
Low
3.00
+527.6%
Consensus
3.00
+527.6%
Median
3.00
+527.6%
High
3.00
+527.6%
DCF (Unlevered)
7.85
+1,541.2%
DCF (Levered)
7.85
+1,541.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
3.00
+527.6%
|
| All Time | 1 |
3.00
+527.6%
|
Quality scores
Altman Z-Score
-1.00
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+77.1% ★ Q1'26: +96.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-34,589.8% Q1'26: -0.4% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+541.5% Q1'26: +2,120.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 EPS Ana. |
Dec 2027 1 EPS Ana. |
Dec 2028 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
15.1K
est: 100.0K (-84.9%)
|
—
est: 500.0K (-100.0%)
|
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBITDA |
-4.51M
est: 60.0K (-7,610.1%)
|
-11.72M
est: 300.0K (-4,007.6%)
|
-13.60M
|
-20.19M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-4.51M
est: 60.0K (-7,612.4%)
|
-11.73M
est: 300.0K (-4,009.3%)
|
-14.25M
|
-20.86M
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-2.17M
est: -7.67M (+71.7%)
|
-13.94M
est: -11.84M (-17.7%)
|
-13.90M
est: -1.64M (-745.7%)
|
-20.43M
est: -10.55M (-93.7%)
|
-13.08M
-13.08M – -13.08M
-24.0% YoY
|
-14.77M
-14.77M – -14.77M
-12.9% YoY
|
-16.17M
-16.17M – -16.17M
-9.5% YoY
|
| SGA |
—
est: 80.0K (-100.0%)
|
9.92M
est: 400.0K (+2,379.6%)
|
7.05M
|
12.88M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.89
est: -7.00 (+73.0%)
|
-10.34
est: -10.80 (+4.3%)
|
-12.69
est: -1.50 (-746.0%)
|
-2.91
est: -1.50 (-94.0%)
|
-1.86
-1.86 – -1.86
-24.0% YoY
|
-2.10
-2.10 – -2.10
-12.9% YoY
|
-2.30
-2.30 – -2.30
-9.5% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-20 | HC Wainwright & Co. | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-14 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-4.80B
OE per share TTM
-198.54
Owner's Yield
-25,278.40%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
6,563.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
8
Total invested
561.4K
Insider transactions (90d)
7
Beneficial owners (>5%)
27
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PD Joint Holdings, LLC, Series 2016-A | 3.41M | 9.80% | 2.61M | — | 2.61M | — | OO | Delaware | 2022-06-29 | ↗ |
| 2 | Paul B. Manning | 2.61M | 9.80% | — | 2.61M | — | 2.61M | IN | Delaware | 2022-06-29 | ↗ |
| 3 | Camac Capital, LLC | 1.79M | 6.70% | — | 1.79M | — | — | OO | Delaware | 2022-11-01 | ↗ |
| 4 | Camac Fund, LP | 1.79M | 6.70% | — | 1.79M | — | — | OO | Delaware | 2022-11-01 | ↗ |
| 5 | Camac Partners, LLC | 1.79M | 6.70% | — | 1.79M | — | — | OO | Delaware | 2022-11-01 | ↗ |
| 6 | Eric Shahinian | 1.79M | 6.70% | — | 1.79M | — | — | IN | United States of America | 2022-11-01 | ↗ |
| 7 | Lawrence Steinman | 1.58M | 6.00% | 1.58M | — | 1.58M | — | IN | United States | 2023-06-08 | ↗ |
| 8 | Uday Khire | 1.47M | 5.00% | 1.47M | — | 1.47M | — | IN | United States | 2022-10-20 | ↗ |
| 9 | Avi Geller | 1.19M | 4.50% | — | 1.19M | — | — | IN | United States of America | 2022-11-01 | ↗ |
| 10 | K2 & ASSOCIATES INVESTMENT MANAGEMENT INC. | 1.09M | 4.99% | — | 1.09M | — | 1.09M | CO | ONTARIO, CANADA | 2022-02-01 | ↗ |
| 11 | K2 Genpar 2017 Inc. | 1.09M | 4.99% | — | 1.09M | — | 1.09M | CO | Ontario, CANADA | 2022-02-01 | ↗ |
| 12 | L.P. | 1.09M | 4.99% | — | 1.09M | — | 1.09M | PN | Ontario, CANADA | 2022-02-01 | ↗ |
| 13 | SHAWN KIMEL INVESTMENTS, INC. | 1.09M | 4.99% | — | 1.09M | — | 1.09M | CO | ONTARIO, CANADA | 2022-02-01 | ↗ |
| 14 | Leonite Capital LLC | 1.03M | 3.90% | — | 1.03M | — | — | OO | Delaware | 2022-11-01 | ↗ |
| 15 | Alpha Capital Anstalt | 831.8K | 6.36% | 831.8K | — | 831.8K | — | CO | Liechtenstein | 2021-11-04 | ↗ |
| 16 | Brendan O’Neil | 756.7K | 5.80% | — | 756.7K | — | 756.7K | IN | California, United States | 2021-09-22 | ↗ |
| 17 | Ionic Ventures, LLC | 756.7K | 5.80% | — | 756.7K | — | 756.7K | OO | California, United States | 2021-09-22 | ↗ |
| 18 | Keith Coulston | 756.7K | 5.80% | — | 756.7K | — | 756.7K | IN | California, United States | 2021-09-22 | ↗ |
| 19 | Delaney | 227.5K | 1.00% | — | 227.5K | — | — | IN | Canada | 2022-11-01 | ↗ |
| 20 | David Delaney | 226.5K | 1.00% | — | 226.5K | — | — | IN | Canada | 2022-06-01 | ↗ |
| 21 | Concord IP2 Ltd. | 191.3K | 1.00% | — | 191.3K | — | — | CO | Province of Ontario | 2022-06-01 | ↗ |
| 22 | IP2 Ltd. | 191.3K | 1.00% | — | 191.3K | — | — | CO | Province of Ontario | 2022-11-01 | ↗ |
| 23 | Fund I, LP | 154.6K | 1.00% | — | 154.6K | — | — | OO | Delaware | 2022-11-01 | ↗ |
| 24 | Armistice Capital, LLC | 115.9K | 9.99% | — | 115.9K | — | — | IA, OO | Delaware | 2024-11-14 | ↗ |
| 25 | Steven Boyd | 115.9K | 9.99% | — | 115.9K | — | — | HC, IN | Delaware | 2024-11-14 | ↗ |
| 26 | Corporation | 36.2K | 1.00% | — | 36.2K | — | — | CO | Province of Ontario | 2022-11-01 | ↗ |
| 27 | Elderhill Corporation | 35.2K | 1.00% | — | 35.2K | — | — | CO | Province of Ontario | 2022-06-01 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
8
-17 vs prev Q
New positions
2
Closed positions
19
Increased
4
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | JANUS HENDERSON GROUP PLC | 2.10M +2.1M (+100.0%) | 2.72M +2.7M (+100.0%) | 28.21% +28.211 pp | 0.00% +0.001 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.10M +2.1M (+100.0%) | 2.71M +2.7M (+100.0%) | 28.21% +28.211 pp | 0.00% +0.004 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 3 | — | 2.10M +2.1M (+100.0%) | 2.71M +2.7M (+100.0%) | 28.21% +28.211 pp | 1.15% +1.148 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 4 | VIVO CAPITAL, LLC | 2.10M +2.1M (+100.0%) | 2.71M +2.7M (+100.0%) | 28.21% +28.211 pp | 0.18% +0.175 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 5 | AMERIPRISE FINANCIAL INC | 1.93M +1.9M (+100.0%) | 2.49M +2.5M (+100.0%) | 25.93% +25.929 pp | 0.00% +0.001 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 6 | CABLE CAR CAPITAL LLC | 500.0K +500.0K (+100.0%) | 645.0K +645.0K (+100.0%) | 6.72% +6.717 pp | 0.02% +0.022 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 7 | ACUTA CAPITAL PARTNERS, LLC | 450.0K +450.0K (+100.0%) | 580.5K +580.5K (+100.0%) | 6.05% +6.045 pp | 0.39% +0.394 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 8 | STEMPOINT CAPITAL LP | 355.1K +355.1K (+100.0%) | 458.1K +458.1K (+100.0%) | 4.77% +4.770 pp | 0.08% +0.079 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 9 | ADVISORSHARES INVESTMENTS LLC | 304.7K +47.0K (+18.2%) | 393.1K +207.5K (+111.8%) | 4.09% +0.632 pp | 0.07% +0.035 pp | USD0.91 +41.8% | 4 qtrs — |
| 10 | PERSISTENT ASSET PARTNERS LTD | 290.6K +290.6K (+100.0%) | 374.8K +374.8K (+100.0%) | 3.90% +3.903 pp | 0.17% +0.168 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 11 | STONEPINE CAPITAL MANAGEMENT, LLC | 275.1K +275.1K (+100.0%) | 354.8K +354.8K (+100.0%) | 3.70% +3.695 pp | 0.26% +0.259 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 12 | VANGUARD GROUP INC | 97.7K +43.9K (+81.5%) | 126.0K +87.3K (+225.2%) | 1.31% +0.589 pp | 0.00% +0.000 pp | USD0.98 +31.6% | 2 qtrs — |
| 13 | JANE STREET GROUP, LLC | 59.4K +34.3K (+137.0%) | 76.6K +58.3K (+317.7%) | 0.80% +0.461 pp | 0.00% +0.000 pp | USD1.05 +22.9% | 2 qtrs — |
| 14 | CITADEL ADVISORS LLC | 56.2K -11.2K (-16.6%) | 72.5K +24.0K (+49.5%) | 0.75% -0.150 pp | 0.00% +0.000 pp | USD0.72 +79.2% | 3 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 54.5K +29.0K (+113.9%) | 70.3K +52.0K (+283.2%) | 0.73% +0.390 pp | 0.00% +0.000 pp | USD1.03 +25.2% | 2 qtrs — |
| 16 | TWO SIGMA INVESTMENTS, LP | 48.8K +13.0K (+36.4%) | 62.9K +36.7K (+140.4%) | 0.66% +0.175 pp | 0.00% +0.000 pp | USD0.88 +46.6% | 2 qtrs — |
| 17 | MAGNOLIA PRIVATE WEALTH, LLC | 33.3K +33.3K (+100.0%) | 43.0K +43.0K (+100.0%) | 0.45% +0.448 pp | 0.03% +0.030 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 18 | NORTHERN TRUST CORP | 28.1K +28.1K (+100.0%) | 36.2K +36.2K (+100.0%) | 0.38% +0.377 pp | 0.00% +0.000 pp | USD1.29 +0.0% | 1 qtrs NEW |
| 19 | XTX TOPCO LTD | 20.8K -13.6K (-39.5%) | 26.8K +2.1K (+8.4%) | 0.28% -0.182 pp | 0.00% -0.001 pp | USD0.73 +76.7% | 2 qtrs — |
| 20 | UBS GROUP AG | 13.3K -5.1K (-27.8%) | 17.1K +3.7K (+27.2%) | 0.18% -0.069 pp | 0.00% +0.000 pp | USD1.09 +18.3% | 8 qtrs — |
| 21 | HURLEY CAPITAL, LLC | 3.7K +— (+0.0%) | 4.8K +2.1K (+76.3%) | 0.05% +0.000 pp | 0.00% +0.001 pp | USD1.30 -0.8% | 4 qtrs — |
| 22 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.9K +1.7K (+142.2%) | 3.8K +2.9K (+326.7%) | 0.04% +0.023 pp | 0.00% +0.000 pp | USD2.01 -35.8% | 8 qtrs — |
| 23 | SBI SECURITIES CO., LTD. | 1.1K +— (+0.0%) | 1.4K +587.0 (+76.3%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD0.72 +79.2% | 3 qtrs — |
| 24 | JPMORGAN CHASE & CO | 150.00 +— (+0.0%) | 194.00 +86.0 (+79.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.23 -82.2% | 8 qtrs — |
| 25 | BANK OF AMERICA CORP /DE/ | 63.00 +5.0 (+8.6%) | 81.00 +38.0 (+88.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.27 +1.6% | 7 qtrs — |
| 26 | RENAISSANCE TECHNOLOGIES LLC | — -30.7K (-100.0%) | — -22.5K (-100.0%) | 0.00% -0.412 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 27 | TWO SIGMA SECURITIES, LLC | — -20.8K (-100.0%) | — -15.3K (-100.0%) | 0.00% -0.280 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 28 | HRT FINANCIAL LP | — -10.9K (-100.0%) | — -7.0K (-100.0%) | 0.00% -0.146 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 29 | VIRTU FINANCIAL LLC | — -25.1K (-100.0%) | — -18.0K (-100.0%) | 0.00% -0.337 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 30 | CITIGROUP INC | — -443.0 (-100.0%) | — -319.0 (-100.0%) | 0.00% -0.006 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | AdvisorShares Psychedelics ETF PSIL | 1.04% | 461.6K | 1.84% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 88.3K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
3.5K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+3,500
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Schneiderman Daniel H | Officer | A-Award | A | Stock Option (right to buy) | 1,129,323 | 0.84 | 949.8K | 1,129,323 | D | ↗ |
| 2026-05-01 | STEINMAN LAWRENCE | Director | A-Award | A | Stock Option (right to buy) | 152,783 | 0.84 | 128.5K | 152,783 | D | ↗ |
| 2026-05-01 | Novak Alfred J | Director | A-Award | A | Stock Option (right to buy) | 152,783 | 0.84 | 128.5K | 152,783 | D | ↗ |
| 2026-05-01 | Marques Tiago | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,756,069 | 0.84 | 1.48M | 1,756,069 | D | ↗ |
| 2026-05-01 | Leahy Emer | Director | A-Award | A | Stock Option (right to buy) | 152,783 | 0.84 | 128.5K | 152,783 | D | ↗ |
| 2026-05-01 | Krishnan Kartik | Officer | A-Award | A | Stock Option (right to buy) | 1,129,323 | 0.84 | 949.8K | 1,129,323 | D | ↗ |
| 2026-05-01 | Dumesnil Simon | Director | A-Award | A | Stock Option (right to buy) | 152,783 | 0.84 | 128.5K | 152,783 | D | ↗ |
| 2026-04-09 | Coastlands Capital LP | 10% Owner | — | — | Pre-funded Warrant | 11,233,334 | 0.00 | 11.2K | 0 | I | ↗ |
| 2025-11-28 | Schneiderman Daniel H | Officer | A-Award | A | Common Stock | 26,667 | 0.75 | 20.0K | 26,667 | D | ↗ |
| 2025-11-28 | STEINMAN LAWRENCE | Director | P-Purchase | A | Common Stock | 133,333 | 0.75 | 100.0K | 199,691 | D | ↗ |
| 2025-11-28 | Marques Tiago | Director / Officer | P-Purchase | A | Common Stock | 33,333 | 0.75 | 25.0K | 73,334 | D | ↗ |
| 2025-11-28 | Leahy Emer | Director | A-Award | A | Common Stock | 33,333 | 0.75 | 25.0K | 33,333 | D | ↗ |
| 2025-11-28 | Dumesnil Simon | Director | P-Purchase | A | Common Stock | 33,333 | 0.75 | 25.0K | 35,833 | D | ↗ |
| 2025-10-24 | Schneiderman Daniel H | Officer | A-Award | A | Stock Option (right to buy) | 317,266 | 0.72 | 226.8K | 317,266 | D | ↗ |
| 2025-10-24 | STEINMAN LAWRENCE | Director | A-Award | A | Stock Option (right to buy) | 242,913 | 0.72 | 173.7K | 242,913 | D | ↗ |
| 2025-10-24 | Novak Alfred J | Director | A-Award | A | Stock Option (right to buy) | 42,913 | 0.72 | 30.7K | 42,913 | D | ↗ |
| 2025-10-24 | Marques Tiago | Director / Officer | A-Award | A | Stock Option (right to buy) | 493,341 | 0.72 | 352.7K | 493,341 | D | ↗ |
| 2025-10-24 | Leahy Emer | Director | A-Award | A | Stock Option (right to buy) | 42,913 | 0.72 | 30.7K | 42,913 | D | ↗ |
| 2025-10-24 | Dumesnil Simon | Director | A-Award | A | Stock Option (right to buy) | 42,913 | 0.72 | 30.7K | 42,913 | D | ↗ |
| 2025-05-12 | Marques Tiago | Director / Officer | S-Sale | D | Common Stock | 960 | 0.83 | 792.00 | 40,001 | D | ↗ |
| 2024-06-13 | Novak Alfred J | Director | A-Award | A | Common Stock | 2,750 | 5.62 | 15.5K | 3,500 | — | ↗ |
| 2024-06-12 | Novak Alfred J | Director | A-Award | A | Common Stock | 750 | 5.61 | 4.2K | 750 | — | ↗ |
| 2024-03-01 | Schneiderman Daniel H | Officer | A-Award | A | Stock Option (right to buy) | 5,927 | 8.34 | 49.4K | 5,927 | — | ↗ |
| 2024-03-01 | STEINMAN LAWRENCE | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 8.34 | 62.6K | 7,500 | — | ↗ |
| 2024-03-01 | Novak Alfred J | Director | A-Award | A | Stock Option (right to buy) | 5,000 | 8.34 | 41.7K | 5,000 | — | ↗ |
| 2024-03-01 | Marques Tiago | Director / Officer | A-Award | A | Stock Option (right to buy) | 11,669 | 8.34 | 97.3K | 11,669 | — | ↗ |
| 2024-03-01 | Leahy Emer | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 8.34 | 62.6K | 7,500 | — | ↗ |
| 2024-03-01 | Dumesnil Simon | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 8.34 | 62.6K | 7,500 | — | ↗ |
| 2024-03-01 | Currie Graeme Martin | Officer | A-Award | A | Stock Option (right to buy) | 5,938 | 8.34 | 49.5K | 5,938 | — | ↗ |
| 2023-06-30 | Currie Graeme Martin | Officer | — | D | Stock Option (right to buy) | 300,000 | 0.49 | 147.3K | 0 | — | ↗ |
| 2023-06-02 | STEINMAN LAWRENCE | Director | P-Purchase | A | Common Stock | 30,000 | 0.43 | 12.9K | 1,327,174 | — | ↗ |
| 2022-12-21 | PD Joint Holdings, LLC Series 2016-A | 10% Owner | — | D | Warrant (right to buy) | 800,000 | 1.88 | 1.50M | 0 | — | ↗ |
| 2022-11-28 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 5,000 | 0.98 | 4.9K | 1,287,174 | — | ↗ |
| 2022-11-25 | Marques Tiago | Officer | A-Award | A | Common Stock | 2,000 | 1.03 | 2.1K | 819,206 | — | ↗ |
| 2022-11-23 | Marques Tiago | Officer | A-Award | A | Common Stock | 5,000 | 1.00 | 5.0K | 815,000 | — | ↗ |
| 2022-11-22 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 5,000 | 0.99 | 5.0K | 1,282,174 | — | ↗ |
| 2022-11-17 | Dumesnil Simon | Director | A-Award | A | Common Stock | 40,000 | 1.06 | 42.4K | 50,000 | — | ↗ |
| 2022-11-15 | Dumesnil Simon | Director | A-Award | A | Common Stock | 10,000 | 1.07 | 10.7K | 10,000 | — | ↗ |
| 2022-10-26 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 5,000 | 1.10 | 5.5K | 1,277,174 | — | ↗ |
| 2022-10-22 | PD Joint Holdings, LLC Series 2016-A | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 2,608,696 | — | ↗ |
| 2022-10-21 | Novak Alfred J | Director | A-Award | A | Stock Option (to acquire Common Stock) | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2022-10-21 | Marques Tiago | Officer | A-Award | A | Common Stock | 4,400 | 1.07 | 4.7K | 810,000 | — | ↗ |
| 2022-10-17 | STEINMAN LAWRENCE | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-10-17 | Delaney David | Director | P-Purchase | A | Common Stock | 1,000 | 1.11 | 1.1K | 227,521 | — | ↗ |
| 2022-10-11 | Schneiderman Daniel H | Officer | A-Award | A | Stock Option (to acquire Common Stock) | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2022-09-29 | Shahinian Eric | 10% Owner | P-Purchase | A | Common Stock | 6,710 | 1.16 | 7.8K | 1,788,415 | — | ↗ |
| 2022-09-28 | Shahinian Eric | 10% Owner | P-Purchase | A | Common Stock | 57,647 | 1.19 | 68.5K | 1,781,705 | — | ↗ |
| 2022-09-28 | Camac Partners, LLC | Director | P-Purchase | A | Common Stock | 6,710 | 1.16 | 7.8K | 1,788,415 | — | ↗ |
| 2022-09-14 | Novak Alfred J | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-09-06 | Shahinian Eric | 10% Owner | P-Purchase | A | Common Stock | 21,748 | 1.13 | 24.6K | 1,724,058 | — | ↗ |
| 2022-09-02 | Shahinian Eric | 10% Owner | P-Purchase | A | Common Stock | 11,507 | 1.14 | 13.1K | 1,702,310 | — | ↗ |
| 2022-09-01 | Shahinian Eric | 10% Owner | P-Purchase | A | Common Stock | 55,646 | 1.13 | 62.6K | 1,690,803 | — | ↗ |
| 2022-09-01 | Camac Partners, LLC | Director | P-Purchase | A | Common Stock | 55,646 | 1.13 | 62.6K | 1,690,803 | — | ↗ |
| 2022-08-30 | Shahinian Eric | 10% Owner | P-Purchase | A | Common Stock | 17,828 | 1.15 | 20.5K | 1,635,157 | — | ↗ |
| 2022-08-29 | Shahinian Eric | 10% Owner | P-Purchase | A | Common Stock | 5,000 | 1.17 | 5.8K | 1,617,329 | — | ↗ |
| 2022-08-29 | Camac Partners, LLC | Director | P-Purchase | A | Common Stock | 17,828 | 1.15 | 20.5K | 1,635,157 | — | ↗ |
| 2022-08-19 | Leonite Fund I, LP | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-19 | Leonite Capital LLC | Director | P-Purchase | A | Common Stock | 54,644 | 1.30 | 70.9K | 54,644 | — | ↗ |
| 2022-08-17 | Shahinian Eric | 10% Owner | P-Purchase | A | Common Stock | 155,773 | 1.21 | 188.3K | 1,611,329 | — | ↗ |
| 2022-08-17 | Camac Partners, LLC | Director | P-Purchase | A | Common Stock | 155,773 | 1.21 | 188.3K | 1,611,329 | — | ↗ |
| 2022-08-12 | Schneiderman Daniel H | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-09 | Shahinian Eric | — | — | I | Common Stock | 0 | 0.00 | — | 1,455,556 | — | ↗ |
| 2022-08-09 | Geller Avi | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,034,702 | — | ↗ |
| 2022-08-09 | Delaney David | — | — | I | Common Stock | 0 | 0.00 | — | 226,521 | — | ↗ |
| 2022-06-29 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 5,000 | 1.00 | 5.0K | 1,272,174 | — | ↗ |
| 2022-06-28 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 5,000 | 1.02 | 5.1K | 1,267,174 | — | ↗ |
| 2022-06-27 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 5,000 | 1.02 | 5.1K | 1,267,174 | — | ↗ |
| 2022-06-23 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 5,000 | 1.00 | 5.0K | 1,257,174 | — | ↗ |
| 2022-06-23 | Marques Tiago | Officer | A-Award | A | Common Stock | 2,900 | 0.99 | 2.9K | 802,900 | — | ↗ |
| 2022-06-21 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 652,174 | 0.00 | — | 1,252,174 | — | ↗ |
| 2021-12-20 | Marques Tiago | Director / Officer | A-Award | A | Common Stock | 200,000 | 0.00 | — | 800,000 | — | ↗ |
| 2021-09-14 | STEINMAN LAWRENCE | Director | — | D | Common Stock | 0 | 0.00 | — | 600,000 | — | ↗ |
| 2021-09-14 | Marques Tiago | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 600,000 | — | ↗ |
| 2021-09-14 | Leahy Emer | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-14 | Lazer Eric | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 902,600 | — | ↗ |
| 2021-09-14 | Lazer Dean | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 902,600 | I | ↗ |
| 2021-09-14 | Gloss Stanley | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-14 | Dumesnil Simon | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-14 | Bendiabdallah Yassine | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 300,000 | — | ↗ |
| 2021-09-14 | Abramowitz Israel Maxx | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,051,575 | — | ↗ |
| 2021-08-02 | STEINMAN LAWRENCE | Director | A-Award | A | Stock option (to acquire common stock) | 100,000 | 6.00 | 600.0K | 100,000 | — | ↗ |
| 2021-08-02 | Dumesnil Simon | Director | A-Award | A | Stock Option (to acquire Common Stock) | 100,000 | 0.00 | — | 100,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
7.44M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Tiago Reis Marques Chief Executive Officer | 450.0K | — | 22.2K | 167.8K | — | — | 640.1K | 29.69% | ↗ |
| 2 | 2024 | Graeme Currie Chief Development Officer | 386.5K | — | — | 48.3K | — | — | 434.8K | 11.10% | ↗ |
| 3 | 2024 | Daniel Schneiderman Chief Financial Officer | 330.0K | — | — | 100.2K | — | — | 430.2K | 23.30% | ↗ |
| 4 | 2023 | Tiago Reis Marques, Chief Executive Officer | 450.0K | 30.0K | 57.3K | — | — | — | 537.3K | 10.67% | ↗ |
| 5 | 2023 | Tiago Reis Marques Chief Executive Officer | 450.0K | 30.0K | 57.3K | — | — | — | 537.3K | 10.67% | ↗ |
| 6 | 2023 | Graeme Currie Chief Development Officer | 330.6K | 16.0K | — | 98.2K | — | — | 444.9K | 22.08% | ↗ |
| 7 | 2023 | Graeme Currie, Chief Development Officer | 330.6K | 16.0K | — | 98.2K | — | — | 444.9K | 22.08% | ↗ |
| 8 | 2023 | Daniel Schneiderman, Chief Financial Officer | 330.0K | 15.9K | — | — | — | — | 345.9K | 0.00% | ↗ |
| 9 | 2023 | Daniel Schneiderman Chief Financial Officer | 330.0K | 15.9K | — | — | — | — | 345.9K | 0.00% | ↗ |
| 10 | 2022 | Tiago Reis Marques, Chief Executive Officer | 450.0K | 89.3K | — | — | — | — | 539.3K | 0.00% | ↗ |
| 11 | 2022 | Daniel Schneiderman, Chief Financial Officer | 135.2K | 57.5K | — | 174.5K | — | — | 367.2K | 47.52% | ↗ |
| 12 | 2022 | Daniel Schneiderman , Chief Financial Officer | 135.2K | 57.5K | — | 174.5K | — | — | 367.2K | 47.52% | ↗ |
| 13 | 2022 | Graeme Currie, Chief Development Officer | 143.9K | 55.0K | — | — | — | — | 198.9K | 0.00% | ↗ |
| 14 | 2022 | Stanley Gloss, Former Chief Financial Officer | 60.0K | — | — | — | — | — | 60.0K | 0.00% | ↗ |
| 15 | 2022 | Stanley M. Gloss, Former Chief Financial Officer | 60.0K | — | — | — | — | — | 60.0K | 0.00% | ↗ |
| 16 | 2021 | Tiago Reis Marques, Chief Executive Officer | 243.8K | — | 288.0K | 140.1K | — | — | 671.9K | 63.72% | ↗ |
| 17 | 2021 | Stanley M. Gloss, Former Chief Financial Officer | 67.5K | — | 60.0K | 284.7K | — | — | 412.2K | 83.62% | ↗ |
| 18 | 2021 | Stanley M. Gloss, Chief Financial Officer | 67.5K | — | 60.0K | 284.7K | — | — | 412.2K | 83.62% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Tiago Reis Marques | Chief Executive Officer & Director | 1M | — |
| Daniel H. Schneiderman | Chief Financial Officer | 716.9K | male |
| Lawrence Steinman | Co-Founder & Executive Chairman | 208.8K | — |
| Kartik Krishnan | Chief Medical Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KTTA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
